Director sold ~$184K of Palantir
Scheduled in advanceTraded Nov 3, 2025 · Filed Nov 6, 2025
Sold under a plan set up in advance, so the timing wasn't a fresh decision
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$467,056
Shares × reported transaction price
on the day of results (Nov 3, 2025), 91 days before results of Feb 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $207.18 on Nov 3, 2025, at its 52-week high, after a 16% rise over the previous 30 trading days
52-week range $41.41 (Nov 4, 2024) to $207.18 (Nov 3, 2025), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $179.33 on Sep 22, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.7% | +0.3% | -1.9% |
| 30 days | +3.7% | +2.0% | +1.7% |
| 90 days | -20.3% | +2.4% | -22.7% |
| 180 days | -22.4% | +8.0% | -30.3% |
Past results only. Not a forecast.
Director sold ~$184K of Palantir
Scheduled in advanceDirector sold ~$242K of Palantir
Scheduled in advanceDirector sold ~$465K of Palantir
Scheduled in advance